Illumina Inc
ILMN94.660USD
-8.050-7.84%
收盘 08/01, 16:00（美东）报价延迟15分钟
15.05B总市值
亏损市盈率 TTM
关于 Illumina Inc 公司
Illumina, Inc. 致力于提供基于测序和阵列的遗传和基因组分析解决方案。其产品和服务服务于各个市场的客户，使基因组解决方案能够在研究和临床环境中得到采用。其 DNA 测序技术基于可逆终止子测序化学，称为合成测序生物化学。其 BeadArray 技术在制造过程中结合了微型珠子和基质，以生产可同时执行多项检测的阵列。其测序应用包括全基因组测序试剂盒（可对任何大小和复杂程度的整个基因组进行测序）和靶向重测序试剂盒（可对外显子组、特定基因、RNA 或其他感兴趣的基因组区域进行测序）。其客户包括基因组研究中心、学术机构、政府实验室、医院、制药、生物技术、商业分子诊断实验室等。
公司简介
公司代码ILMN
公司名称Illumina Inc
上市日期Jun 28, 2000
成立日期2000
CEOMr. Jacob Thaysen, Ph.D.
员工数量8970
证券类型Ordinary Share
年结日Jun 28
公司地址5200 Illumina Way
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编92122
电话18582024500
网址https://www.illumina.com
公司代码ILMN
上市日期Jun 28, 2000
成立日期2000
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jacob Thaysen, Ph.D.
Mr. Jacob Thaysen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
24.94K
+98.06%
Dr. Robert S. (Rob) Epstein, M.D.
Dr. Robert S. (Rob) Epstein, M.D.
Independent Director
Independent Director
22.14K
+20.59%
Dr. Frances H. Arnold, Ph.D.
Dr. Frances H. Arnold, Ph.D.
Independent Director
Independent Director
21.03K
+21.92%
Mr. Philip W. (Phil) Schiller
Mr. Philip W. (Phil) Schiller
Independent Director
Independent Director
20.15K
+23.09%
Ms. Patricia (Pat) Leckman
Ms. Patricia (Pat) Leckman
Chief People Officer
Chief People Officer
19.25K
+60.86%
Mr. Scott Davies
Mr. Scott Davies
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
18.93K
+58.70%
Dr. Steven (Steve) Barnard, Ph.D.
Dr. Steven (Steve) Barnard, Ph.D.
Chief Technology Officer
Chief Technology Officer
17.13K
-31.74%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Independent Director
Independent Director
16.43K
+29.88%
Ms. Caroline D. Dorsa
Ms. Caroline D. Dorsa
Independent Director
Independent Director
15.19K
+21.71%
Ms. Susan E. (Sue) Siegel
Ms. Susan E. (Sue) Siegel
Independent Director
Independent Director
14.46K
+35.38%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jacob Thaysen, Ph.D.
Mr. Jacob Thaysen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
24.94K
+98.06%
Dr. Robert S. (Rob) Epstein, M.D.
Dr. Robert S. (Rob) Epstein, M.D.
Independent Director
Independent Director
22.14K
+20.59%
Dr. Frances H. Arnold, Ph.D.
Dr. Frances H. Arnold, Ph.D.
Independent Director
Independent Director
21.03K
+21.92%
Mr. Philip W. (Phil) Schiller
Mr. Philip W. (Phil) Schiller
Independent Director
Independent Director
20.15K
+23.09%
Ms. Patricia (Pat) Leckman
Ms. Patricia (Pat) Leckman
Chief People Officer
Chief People Officer
19.25K
+60.86%
Mr. Scott Davies
Mr. Scott Davies
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
18.93K
+58.70%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Consumables
768.00M
73.78%
Services and Other revenue
161.00M
15.47%
Instruments
112.00M
10.76%
地区USD
名称
营收
占比
Americas
570.00M
54.76%
Europe
293.00M
28.15%
Asia, Middle East, and Africa
106.00M
10.18%
Greater China
72.00M
6.92%
业务
地区
业务USD
名称
营收
占比
Consumables
768.00M
73.78%
Services and Other revenue
161.00M
15.47%
Instruments
112.00M
10.76%
股东统计
更新时间: 14 小时前
更新时间: 14 小时前
持股股东
股东类型
持股股东
持股股东
占比
Capital World Investors
11.94%
The Vanguard Group, Inc.
10.29%
BlackRock Institutional Trust Company, N.A.
8.85%
Capital Research Global Investors
4.17%
State Street Global Advisors (US)
3.70%
Other
61.04%
持股股东
持股股东
占比
Capital World Investors
11.94%
The Vanguard Group, Inc.
10.29%
BlackRock Institutional Trust Company, N.A.
8.85%
Capital Research Global Investors
4.17%
State Street Global Advisors (US)
3.70%
Other
61.04%
股东类型
持股股东
占比
Investment Advisor
55.86%
Investment Advisor/Hedge Fund
26.27%
Hedge Fund
10.41%
Pension Fund
2.98%
Research Firm
2.52%
Bank and Trust
1.81%
Sovereign Wealth Fund
1.19%
Individual Investor
0.18%
Insurance Company
0.09%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1970
169.77M
107.25%
-17.38M
2025Q1
2072
170.79M
107.89%
-16.32M
2024Q4
2074
166.23M
104.94%
-15.71M
2024Q3
2038
151.41M
95.06%
-11.30M
2024Q2
2033
149.41M
93.80%
-18.06M
2024Q1
2096
153.02M
96.09%
-8.97M
2023Q4
2134
150.48M
94.76%
-5.28M
2023Q3
2162
152.18M
96.14%
-14.52M
2023Q2
2203
154.10M
97.47%
-5.40M
2023Q1
2219
149.37M
94.55%
-9.34M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Capital World Investors
18.90M
11.94%
+874.11K
+4.85%
Mar 31, 2025
The Vanguard Group, Inc.
16.30M
10.29%
+552.07K
+3.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
14.01M
8.85%
-14.57K
-0.10%
Mar 31, 2025
Capital Research Global Investors
8.64M
5.46%
+630.00
+0.01%
May 31, 2025
State Street Global Advisors (US)
5.85M
3.7%
+58.31K
+1.01%
Mar 31, 2025
WCM Investment Management
4.18M
2.64%
+49.16K
+1.19%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
4.15M
2.62%
-62.95K
-1.50%
Mar 31, 2025
Corvex Management LP
3.83M
2.42%
+2.13M
+125.25%
Mar 31, 2025
Baillie Gifford & Co.
3.01M
1.9%
-7.40K
-0.25%
Mar 31, 2025
Brown Advisory
2.91M
1.84%
+996.59K
+52.11%
Mar 31, 2025
查看更多
持股ETF
更新时间: 10 小时前
更新时间: 10 小时前
机构名称
占比
Invesco Biotechnology & Genome ETF
5.63%
Global X Genomics & Biotechnology ETF
4.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
4.18%
First Trust NYSE Arca Biotechnology Index Fund
4.01%
VanEck Biotech ETF
3.01%
ARK Genomic Revolution ETF
2.5%
First Trust NASDAQ Pharmaceuticals ETF
2.01%
ROBO Global Healthcare Technology & Innovation ETF
2%
Alger Russell Innovation ETF
1.96%
Abacus FCF Innovation Leaders ETF
1.86%
查看更多
Invesco Biotechnology & Genome ETF
占比5.63%
Global X Genomics & Biotechnology ETF
占比4.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比4.18%
First Trust NYSE Arca Biotechnology Index Fund
占比4.01%
VanEck Biotech ETF
占比3.01%
ARK Genomic Revolution ETF
占比2.5%
First Trust NASDAQ Pharmaceuticals ETF
占比2.01%
ROBO Global Healthcare Technology & Innovation ETF
占比2%
Alger Russell Innovation ETF
占比1.96%
Abacus FCF Innovation Leaders ETF
占比1.86%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
